BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 19859817)

  • 1. Strong expression of chemokine receptor CXCR4 by renal cell carcinoma cells correlates with metastasis.
    Wang L; Wang L; Yang B; Yang Q; Qiao S; Wang Y; Sun Y
    Clin Exp Metastasis; 2009; 26(8):1049-54. PubMed ID: 19859817
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression and prognostic value of CXCL12/CXCR4/CXCR7 axis in clear cell renal cell carcinoma.
    Potić Floranović M; Ristić Petrović A; Veličković F; Janković Veličković L
    Clin Exp Nephrol; 2021 Oct; 25(10):1057-1069. PubMed ID: 34109508
    [TBL] [Abstract][Full Text] [Related]  

  • 3. pVHL co-ordinately regulates CXCR4/CXCL12 and MMP2/MMP9 expression in human clear-cell renal cell carcinoma.
    Struckmann K; Mertz K; Steu S; Storz M; Staller P; Krek W; Schraml P; Moch H
    J Pathol; 2008 Mar; 214(4):464-71. PubMed ID: 18189328
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemokine and chemokine receptor expression in kidney tumors: molecular profiling of histological subtypes and association with metastasis.
    Gahan JC; Gosalbez M; Yates T; Young EE; Escudero DO; Chi A; Garcia-Roig M; Satyanarayana R; Soloway MS; Bird VG; Lokeshwar VB
    J Urol; 2012 Mar; 187(3):827-33. PubMed ID: 22245330
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stromal derived factor-1 (SDF-1/CXCL12) and CXCR4 in renal cell carcinoma metastasis.
    Pan J; Mestas J; Burdick MD; Phillips RJ; Thomas GV; Reckamp K; Belperio JA; Strieter RM
    Mol Cancer; 2006 Nov; 5():56. PubMed ID: 17083723
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of CXCL12 and Its Receptors on Unpredictable Renal Cell Carcinoma.
    Floranović MP; Veličković LJ
    Clin Genitourin Cancer; 2020 Aug; 18(4):e337-e342. PubMed ID: 31882334
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of stromal derived factor-1 (SDF-1) and chemokine receptor (CXCR4) in bone metastasis of renal carcinoma.
    Zhao FL; Guo W
    Mol Biol Rep; 2011 Feb; 38(2):1039-45. PubMed ID: 20563655
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inflammatory CXCL12-CXCR4/CXCR7 axis mediates G-protein signaling pathway to influence the invasion and migration of nasopharyngeal carcinoma cells.
    Qiao N; Wang L; Wang T; Li H
    Tumour Biol; 2016 Jun; 37(6):8169-79. PubMed ID: 26715277
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A feed-forward loop between nuclear translocation of CXCR4 and HIF-1α promotes renal cell carcinoma metastasis.
    Bao Y; Wang Z; Liu B; Lu X; Xiong Y; Shi J; Li P; Chen J; Zhang Z; Chen M; Wang L; Wu Z
    Oncogene; 2019 Feb; 38(6):881-895. PubMed ID: 30177838
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of CXCL12-CXCR4 axis in ovarian cancer metastasis and CXCL12-CXCR4 blockade with AMD3100 suppresses tumor cell migration and invasion in vitro.
    Liu Y; Ren CC; Yang L; Xu YM; Chen YN
    J Cell Physiol; 2019 Apr; 234(4):3897-3909. PubMed ID: 30191987
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CXCR4 chemokine receptor engagement modifies integrin dependent adhesion of renal carcinoma cells.
    Jones J; Marian D; Weich E; Engl T; Wedel S; Relja B; Jonas D; Blaheta RA
    Exp Cell Res; 2007 Nov; 313(19):4051-65. PubMed ID: 17706641
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Downregulation of the CXCR4/CXCL12 axis blocks the activation of the Wnt/β-catenin pathway in human colon cancer cells.
    Song ZY; Gao ZH; Chu JH; Han XZ; Qu XJ
    Biomed Pharmacother; 2015 Apr; 71():46-52. PubMed ID: 25960214
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The importance of the CXCL12-CXCR4 chemokine ligand-receptor interaction in prostate cancer metastasis.
    Arya M; Patel HR; McGurk C; Tatoud R; Klocker H; Masters J; Williamson M
    J Exp Ther Oncol; 2004 Dec; 4(4):291-303. PubMed ID: 15844659
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monomeric and dimeric CXCL12 inhibit metastasis through distinct CXCR4 interactions and signaling pathways.
    Drury LJ; Ziarek JJ; Gravel S; Veldkamp CT; Takekoshi T; Hwang ST; Heveker N; Volkman BF; Dwinell MB
    Proc Natl Acad Sci U S A; 2011 Oct; 108(43):17655-60. PubMed ID: 21990345
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential Expression and Clinical Relevance of C-X-C Motif Chemokine Receptor 4 (CXCR4) in Renal Cell Carcinomas, Benign Renal Tumors, and Metastases.
    Maas M; Kurcz A; Hennenlotter J; Scharpf M; Fend F; Walz S; Stühler V; Todenhöfer T; Stenzl A; Bedke J; Rausch S
    Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982302
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CXCR4 nuclear localization follows binding of its ligand SDF-1 and occurs in metastatic but not primary renal cell carcinoma.
    Wang L; Wang Z; Yang B; Yang Q; Wang L; Sun Y
    Oncol Rep; 2009 Dec; 22(6):1333-9. PubMed ID: 19885584
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Silencing of CXCR4 by RNA interference inhibits cell growth and metastasis in human renal cancer cells.
    Wang L; Huang T; Chen W; Gao X; Zhou T; Wu Z; Sun Y
    Oncol Rep; 2012 Dec; 28(6):2043-8. PubMed ID: 22972438
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CXC chemokine receptor 4 is essential for maintenance of renal cell carcinoma-initiating cells and predicts metastasis.
    Gassenmaier M; Chen D; Buchner A; Henkel L; Schiemann M; Mack B; Schendel DJ; Zimmermann W; Pohla H
    Stem Cells; 2013 Aug; 31(8):1467-76. PubMed ID: 23630186
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of CXCL12 and its receptor CXCR4 correlates with lymph node metastasis in submucosal esophageal cancer.
    Sasaki K; Natsugoe S; Ishigami S; Matsumoto M; Okumura H; Setoyama T; Uchikado Y; Kita Y; Tamotsu K; Sakurai T; Owaki T; Aikou T
    J Surg Oncol; 2008 Apr; 97(5):433-8. PubMed ID: 18176915
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The CXCL12-CXCR4 axis promotes migration, invasiveness, and EMT in human papillary thyroid carcinoma B-CPAP cells via NF-κB signaling.
    Lin Y; Ma Q; Li L; Wang H
    Biochem Cell Biol; 2018 Oct; 96(5):619-626. PubMed ID: 29316404
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.